Human Gene Therapy Market Size, Share, Growth, and Industry Analysis, By Types (Non-viral Vectors,Viral Vectors), Applications (Neurological Diseases,Cancer,DMD (Duchenne Muscular Dystrophy),Hepatological Diseases,Others), and Regional Insights and Forecast to 2033

Detailed TOC of Global Human Gene Therapy Market Research Report 2025

1 Human Gene Therapy Market Overview
1.1 Product Definition
1.2 Human Gene Therapy by Type
1.2.1 Global Human Gene Therapy Market Value Comparison by Type (2024 VS 2031)
1.2.2 Non-viral Vectors
1.2.3 Viral Vectors
1.3 Human Gene Therapy by Application
1.3.1 Global Human Gene Therapy Market Value by Application (2024 VS 2031)
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 DMD (Duchenne Muscular Dystrophy)
1.3.5 Hepatological Diseases
1.3.6 Others
1.4 Global Human Gene Therapy Market Size Estimates and Forecasts
1.4.1 Global Human Gene Therapy Revenue 2020-2031
1.4.2 Global Human Gene Therapy Sales 2020-2031
1.4.3 Global Human Gene Therapy Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Human Gene Therapy Market Competition by Manufacturers
2.1 Global Human Gene Therapy Sales Market Share by Manufacturers (2020-2025)
2.2 Global Human Gene Therapy Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Human Gene Therapy Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Human Gene Therapy, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Gene Therapy, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Gene Therapy, Product Type & Application
2.7 Global Key Manufacturers of Human Gene Therapy, Date of Enter into This Industry
2.8 Global Human Gene Therapy Market Competitive Situation and Trends
2.8.1 Global Human Gene Therapy Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Human Gene Therapy Players Market Share by Revenue
2.8.3 Global Human Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Human Gene Therapy Market Scenario by Region
3.1 Global Human Gene Therapy Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Human Gene Therapy Sales by Region: 2020-2031
3.2.1 Global Human Gene Therapy Sales by Region: 2020-2025
3.2.2 Global Human Gene Therapy Sales by Region: 2026-2031
3.3 Global Human Gene Therapy Revenue by Region: 2020-2031
3.3.1 Global Human Gene Therapy Revenue by Region: 2020-2025
3.3.2 Global Human Gene Therapy Revenue by Region: 2026-2031
3.4 North America Human Gene Therapy Market Facts & Figures by Country
3.4.1 North America Human Gene Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Human Gene Therapy Sales by Country (2020-2031)
3.4.3 North America Human Gene Therapy Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Human Gene Therapy Market Facts & Figures by Country
3.5.1 Europe Human Gene Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Human Gene Therapy Sales by Country (2020-2031)
3.5.3 Europe Human Gene Therapy Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Gene Therapy Market Facts & Figures by Region
3.6.1 Asia Pacific Human Gene Therapy Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Human Gene Therapy Sales by Region (2020-2031)
3.6.3 Asia Pacific Human Gene Therapy Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Human Gene Therapy Market Facts & Figures by Country
3.7.1 Latin America Human Gene Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Human Gene Therapy Sales by Country (2020-2031)
3.7.3 Latin America Human Gene Therapy Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Gene Therapy Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Gene Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Human Gene Therapy Sales by Country (2020-2031)
3.8.3 Middle East and Africa Human Gene Therapy Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Gene Therapy Sales by Type (2020-2031)
4.1.1 Global Human Gene Therapy Sales by Type (2020-2025)
4.1.2 Global Human Gene Therapy Sales by Type (2026-2031)
4.1.3 Global Human Gene Therapy Sales Market Share by Type (2020-2031)
4.2 Global Human Gene Therapy Revenue by Type (2020-2031)
4.2.1 Global Human Gene Therapy Revenue by Type (2020-2025)
4.2.2 Global Human Gene Therapy Revenue by Type (2026-2031)
4.2.3 Global Human Gene Therapy Revenue Market Share by Type (2020-2031)
4.3 Global Human Gene Therapy Price by Type (2020-2031)
5 Segment by Application
5.1 Global Human Gene Therapy Sales by Application (2020-2031)
5.1.1 Global Human Gene Therapy Sales by Application (2020-2025)
5.1.2 Global Human Gene Therapy Sales by Application (2026-2031)
5.1.3 Global Human Gene Therapy Sales Market Share by Application (2020-2031)
5.2 Global Human Gene Therapy Revenue by Application (2020-2031)
5.2.1 Global Human Gene Therapy Revenue by Application (2020-2025)
5.2.2 Global Human Gene Therapy Revenue by Application (2026-2031)
5.2.3 Global Human Gene Therapy Revenue Market Share by Application (2020-2031)
5.3 Global Human Gene Therapy Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Biogen
6.1.1 Biogen Company Information
6.1.2 Biogen Description and Business Overview
6.1.3 Biogen Human Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Biogen Human Gene Therapy Product Portfolio
6.1.5 Biogen Recent Developments/Updates
6.2 Sarepta Therapeutics
6.2.1 Sarepta Therapeutics Company Information
6.2.2 Sarepta Therapeutics Description and Business Overview
6.2.3 Sarepta Therapeutics Human Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sarepta Therapeutics Human Gene Therapy Product Portfolio
6.2.5 Sarepta Therapeutics Recent Developments/Updates
6.3 Gilead Sciences
6.3.1 Gilead Sciences Company Information
6.3.2 Gilead Sciences Description and Business Overview
6.3.3 Gilead Sciences Human Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Gilead Sciences Human Gene Therapy Product Portfolio
6.3.5 Gilead Sciences Recent Developments/Updates
6.4 Amgen
6.4.1 Amgen Company Information
6.4.2 Amgen Description and Business Overview
6.4.3 Amgen Human Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Amgen Human Gene Therapy Product Portfolio
6.4.5 Amgen Recent Developments/Updates
6.5 Novartis
6.5.1 Novartis Company Information
6.5.2 Novartis Description and Business Overview
6.5.3 Novartis Human Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Novartis Human Gene Therapy Product Portfolio
6.5.5 Novartis Recent Developments/Updates
6.6 Orchard Therapeutics
6.6.1 Orchard Therapeutics Company Information
6.6.2 Orchard Therapeutics Description and Business Overview
6.6.3 Orchard Therapeutics Human Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Orchard Therapeutics Human Gene Therapy Product Portfolio
6.6.5 Orchard Therapeutics Recent Developments/Updates
6.7 Spark Therapeutics
6.7.1 Spark Therapeutics Company Information
6.7.2 Spark Therapeutics Description and Business Overview
6.7.3 Spark Therapeutics Human Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Spark Therapeutics Human Gene Therapy Product Portfolio
6.7.5 Spark Therapeutics Recent Developments/Updates
6.8 Agc Biologics
6.8.1 Agc Biologics Company Information
6.8.2 Agc Biologics Description and Business Overview
6.8.3 Agc Biologics Human Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Agc Biologics Human Gene Therapy Product Portfolio
6.8.5 Agc Biologics Recent Developments/Updates
6.9 Anges
6.9.1 Anges Company Information
6.9.2 Anges Description and Business Overview
6.9.3 Anges Human Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Anges Human Gene Therapy Product Portfolio
6.9.5 Anges Recent Developments/Updates
6.10 Bluebird Bio
6.10.1 Bluebird Bio Company Information
6.10.2 Bluebird Bio Description and Business Overview
6.10.3 Bluebird Bio Human Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Bluebird Bio Human Gene Therapy Product Portfolio
6.10.5 Bluebird Bio Recent Developments/Updates
6.11 Jazz Pharmaceuticals
6.11.1 Jazz Pharmaceuticals Company Information
6.11.2 Jazz Pharmaceuticals Description and Business Overview
6.11.3 Jazz Pharmaceuticals Human Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Jazz Pharmaceuticals Human Gene Therapy Product Portfolio
6.11.5 Jazz Pharmaceuticals Recent Developments/Updates
6.12 Dynavax Technologies
6.12.1 Dynavax Technologies Company Information
6.12.2 Dynavax Technologies Description and Business Overview
6.12.3 Dynavax Technologies Human Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Dynavax Technologies Human Gene Therapy Product Portfolio
6.12.5 Dynavax Technologies Recent Developments/Updates
6.13 Human Stem Cells Institute
6.13.1 Human Stem Cells Institute Company Information
6.13.2 Human Stem Cells Institute Description and Business Overview
6.13.3 Human Stem Cells Institute Human Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Human Stem Cells Institute Human Gene Therapy Product Portfolio
6.13.5 Human Stem Cells Institute Recent Developments/Updates
6.14 Sibiono Genetech
6.14.1 Sibiono Genetech Company Information
6.14.2 Sibiono Genetech Description and Business Overview
6.14.3 Sibiono Genetech Human Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Sibiono Genetech Human Gene Therapy Product Portfolio
6.14.5 Sibiono Genetech Recent Developments/Updates
6.15 Shanghai Sunway Biotech
6.15.1 Shanghai Sunway Biotech Company Information
6.15.2 Shanghai Sunway Biotech Description and Business Overview
6.15.3 Shanghai Sunway Biotech Human Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Shanghai Sunway Biotech Human Gene Therapy Product Portfolio
6.15.5 Shanghai Sunway Biotech Recent Developments/Updates
6.16 Uniqure N.V.
6.16.1 Uniqure N.V. Company Information
6.16.2 Uniqure N.V. Description and Business Overview
6.16.3 Uniqure N.V. Human Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Uniqure N.V. Human Gene Therapy Product Portfolio
6.16.5 Uniqure N.V. Recent Developments/Updates
6.17 Gensight Biologics S.A.
6.17.1 Gensight Biologics S.A. Company Information
6.17.2 Gensight Biologics S.A. Description and Business Overview
6.17.3 Gensight Biologics S.A. Human Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Gensight Biologics S.A. Human Gene Therapy Product Portfolio
6.17.5 Gensight Biologics S.A. Recent Developments/Updates
6.18 Celgene Corporation
6.18.1 Celgene Corporation Company Information
6.18.2 Celgene Corporation Description and Business Overview
6.18.3 Celgene Corporation Human Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Celgene Corporation Human Gene Therapy Product Portfolio
6.18.5 Celgene Corporation Recent Developments/Updates
6.19 Cellectis
6.19.1 Cellectis Company Information
6.19.2 Cellectis Description and Business Overview
6.19.3 Cellectis Human Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Cellectis Human Gene Therapy Product Portfolio
6.19.5 Cellectis Recent Developments/Updates
6.20 Sangamo Therapeutics
6.20.1 Sangamo Therapeutics Company Information
6.20.2 Sangamo Therapeutics Description and Business Overview
6.20.3 Sangamo Therapeutics Human Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Sangamo Therapeutics Human Gene Therapy Product Portfolio
6.20.5 Sangamo Therapeutics Recent Developments/Updates
6.21 Mustang Bio
6.21.1 Mustang Bio Company Information
6.21.2 Mustang Bio Description and Business Overview
6.21.3 Mustang Bio Human Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Mustang Bio Human Gene Therapy Product Portfolio
6.21.5 Mustang Bio Recent Developments/Updates
6.22 AGTC
6.22.1 AGTC Company Information
6.22.2 AGTC Description and Business Overview
6.22.3 AGTC Human Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.22.4 AGTC Human Gene Therapy Product Portfolio
6.22.5 AGTC Recent Developments/Updates
6.23 Poseida Therapeutics
6.23.1 Poseida Therapeutics Company Information
6.23.2 Poseida Therapeutics Description and Business Overview
6.23.3 Poseida Therapeutics Human Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.23.4 Poseida Therapeutics Human Gene Therapy Product Portfolio
6.23.5 Poseida Therapeutics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Gene Therapy Industry Chain Analysis
7.2 Human Gene Therapy Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Gene Therapy Production Mode & Process Analysis
7.4 Human Gene Therapy Sales and Marketing
7.4.1 Human Gene Therapy Sales Channels
7.4.2 Human Gene Therapy Distributors
7.5 Human Gene Therapy Customer Analysis
8 Human Gene Therapy Market Dynamics
8.1 Human Gene Therapy Industry Trends
8.2 Human Gene Therapy Market Drivers
8.3 Human Gene Therapy Market Challenges
8.4 Human Gene Therapy Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer